Search Results - "Benedit, Patricia"

PTOV1 Enables the Nuclear Translocation and Mitogenic Activity of Flotillin-1, a Major Protein of Lipid Rafts by Santamaría, Anna, Castellanos, Elisabeth, Gómez, Valentí, Benedit, Patricia, Renau-Piqueras, Jaime, Morote, Juan, Reventós, Jaume, Thomson, Timothy M, Paciucci, Rosanna

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study by Carrato, Alfredo, García, Pilar, López, Rafael, Macarulla, Teresa, Rivera, Fernando, Sastre, Javier, Gostkorzewicz, Joana, Benedit, Patricia, Pérez-Alcántara, Ferran

“…The PANCOSTABRAX study evaluated the cost-effectiveness of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine (GEM) versus…”
Get more information

Darbepoetin α for the treatment of anemia in patients with myelodysplastic syndromes by Giraldo, Pilar, Nomdedeu, Benet, Loscertales, Javier, Requena, Carmen, de Paz, Raquel, Tormo, Mar, Navarro, Pilar, Benedit, Patricia, Gasquet, José Antonio

“…BACKGROUND. Anemia occurs as a comorbidity in from 80% to 85% of patients with myelodysplastic syndromes (MDS): It causes fatigue, increases transfusion needs,…”
Get full text

PTOV-1, a Novel Protein Overexpressed in Prostate Cancer, Shuttles between the Cytoplasm and the Nucleus and Promotes Entry into the S Phase of the Cell Division Cycle by Santamaría, Anna, Fernández, Pedro L., Farré, Xavier, Benedit, Patricia, Reventós, Jaume, Morote, Juan, Paciucci, Rosanna, Thomson, Timothy M.

“…PTOV1 was recently identified as a novel gene and protein during a differential display screening for genes overexpressed in prostate cancer. The PTOV1 protein…”
Get full text

A Prospective, Observational Study on the Incidence of Chemotherapy-Induced Neutropenia in Lymphoma Patients by Salar, Antonio, López, Andrés, Torres, Juan Pío, López, María Dolores, Prieto, Elena, Caballero, Dolores, Giraldo, Pilar, Batlle, Montserrat, Benedit, Patricia, Garrido, Teresa

“…Background. Neutropenia is a common toxicity in patients (pts) with lymphoma (lymph) who receive myeloablative chemotherapy (CT). It frequently leads to CT…”
Get full text

Darbepoetin Alfa for the Treatment of Anemia in Patients with Myelodysplastic Syndrome by Giraldo, Pilar, Nomdedeu, Benet, Loscertales, Javier, Requena, Carmen, de Paz, Raquel, Tormo, Mar, Navarro, Pilar, Benedit, Patricia, Gasquet, Jose Antonio

“…Background: Anemia is one of the main problems associated with myelodysplastic syndrome (MDS) leading to fatigue, increased red blood cell transfusions, and…”
Get full text

PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks by BENEDIT, Patricia, PACIUCCI, Rosanna, REVENTOS, Jaume, THOMSON, Timothy M, VALERI, Marta, NADAL, Marga, CACERES, Carme, DE TORRES, Inés, ESTIVILL, Xavier, LOZANO, Juan José, MOROTE, Joan

“…In a search for molecular markers of progression in prostate cancer by means of differential display, we have identified a new gene, which we have designated…”
Get full text

Human hormone-refractory prostate cancers can harbor mutations in the O2-dependent degradation domain of hypoxia inducible factor-1α (HIF-1α) by ANASTASIADIS, Aristotelis G, GHAFAR, Mohamed A, BUTTYAN, Ralph, SALOMON, Laurent, VACHEROT, Francis, BENEDIT, Patricia, CHEN, Min-Wei, SHABSIGH, Ahmad, BURCHARDT, Martin, CHOPIN, Dominique K, SHABSIGH, Ridwan

Get full text

Human hormone-refractory prostate cancers can harbor mutations in the O 2 -dependent degradation domain of hypoxia inducible factor-1α (HIF-1α) by Anastasiadis, Aristotelis, Ghafar, Mohamed, Salomon, Laurent, Vacherot, Francis, Benedit, Patricia, Chen, Min-Wei, Shabsigh, Ahmad, Burchardt, Martin, Chopin, Dominique, Shabsigh, Ridwan, Buttyan, Ralph

Get full text

Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha) by Anastasiadis, Aristotelis G, Ghafar, Mohamed A, Salomon, Laurent, Vacherot, Francis, Benedit, Patricia, Chen, Min-Wei, Shabsigh, Ahmad, Burchardt, Martin, Chopin, Dominique K, Shabsigh, Ridwan, Buttyan, Ralph

“…Androgen ablation, the preferred therapy for advanced prostate cancer, reduces blood flow and induces hypoxia in androgen-dependent tissues. Given the…”
Get full text

Human hormone-refractory prostate cancers can harbor mutations in the O2-dependent degradation domain of hypoxia inducible factor-1[alpha] (HIF-1[alpha]) by Anastasiadis, Aristotelis G, Ghafar, Mohamed A, Salomon, Laurent, Vacherot, Francis, Benedit, Patricia, Min-Wei, Chen, Shabsigh, Ahmad, Burchardt, Martin, Chopin, Dominique K, Shabsigh, Ridwan, Buttyan, Ralph

“…Purpose. Androgen ablation, the preferred therapy for advanced prostate cancer, reduces blood flow and induces hypoxia in androgen-dependent tissues. Given the…”
Get full text